STUDY SEARCH RESULTS

1 study found for your search request:  7339-008

A Study of Pembrolizumab (MK-3475) with or without Maintenance Olaparib in First-line Metastatic Squ...
Condition: Carcinoma, squamous cell, non-small-cell lung
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT03976362
Status: Active, not recruiting




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site